Stock Research: IRIDEX

Independent stock analysis through peer comparison: Get the 360° View as an objective basis for stock decision-making and explore the detailed ranks.

IRIDEX

NAQ:IRIX US4626841013
100
  • Value
    96
  • Growth
    13
  • Safety
    Safety
    87
  • Combined
    89
  • Sentiment
    90
  • 360° View
    360° View
    100
Unlock
What factors are driving this 360° View?
Subscribe to View
Company Description

IRIDEX Corporation is an ophthalmic medical technology company that develops and commercializes products and procedures for sight-threatening eye conditions. It operates in the medical technology industry, focusing on glaucoma and retinal diseases with products like MicroPulse Technology, Endpoint Management Technology, Cyclo G6 laser system, OcuLight TX/SLx laser photocoagulation systems, portable IQ 532/577 laser systems, and various laser probes. In the last fiscal year, the company had 93 employees, a market cap of $17 million, profits of $20 million, and revenue of $49 million.

more
Index
Similar Add to Watchlist Similar See Similar Stocks
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 27-Feb-2026.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
96 51 61 71
Growth
13 19 33 65
Safety
Safety
87 73 69 69
Sentiment
90 14 13 68
360° View
360° View
100 50 18 88
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Analyst Opinions
100 5 5 94
Opinions Change
100 50 50 50
Pro Holdings
n/a 1 43 6
Market Pulse
5 15 12 73
Sentiment
90 14 13 68
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
96 51 61 71
Growth
13 19 33 65
Safety Safety
87 73 69 69
Combined
89 82 95 95
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Price vs. Sales (P/S)
97 89 93 95
Price vs. Earnings (P/E)
81 52 52 52
Price vs. Book (P/B)
87 20 49 62
Dividend Yield
1 1 1 1
Value
96 51 61 71
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Revenue Growth
6 13 11 43
Profit Growth
55 65 41 59
Capital Growth
4 42 39 85
Stock Returns
51 15 73 57
Growth
13 19 33 65
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Leverage
26 100 100 65
Refinancing
86 78 79 81
Liquidity
85 1 49 49
Safety Safety
87 73 69 69

Similar Stocks

Discover high‑ranked alternatives to IRIDEX and broaden your portfolio horizons.

Global Payments

NYQ:GPN
Country: USA
Industry: Other Financial Services
Size: X-Large
Full Stock Analysis

Omnicom

NYQ:OMC
Country: USA
Industry: Advertising
Size: X-Large
Full Stock Analysis

Mosaic

NYQ:MOS
Country: USA
Industry: Fertilizers & Agricultural Chemicals
Size: X-Large
Full Stock Analysis

Labcorp

NYQ:LH
Country: USA
Industry: Health Care Services
Size: X-Large
Full Stock Analysis

Frequently Asked
Questions

This stock is a good value with safe financing, but has low growth and negative sentiment. It is a good option for a cautious value investor looking for stability but who can tolerate low momentum and skeptical professional opinion.

Obermatt provides unbiased stock analysis as a completely independent third party. We have no conflicts of interest with individual stock titles. Our data-driven analysis is based on algorithms honed over twelve years, giving you analysis that is free from personal bias and conflicts of interest.

The 360° View Rank indicates a company's overall performance across all major financial and non-financial metrics tracked by Obermatt. A 360° View Rank of 75 means the company is more well-rounded than 75% of similar companies. A high score indicates that the company is strong across the board; it is attractively priced, growing sustainably, financially stable, and well-regarded by the market. Learn more.

Become an Obermatt subscriber and see all of the similar stocks here.

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.

What Our Customers Say

See how Obermatt improved their investing: